Drug intelligence / Profile preview

corydalis rhizoma

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Corydalis rhizoma is the dried tuber (rhizome) of the plant Corydalis yanhusuo W.T. Wang (family Papaveraceae), widely used in traditional Chinese medicine. It is primarily known for its analgesic (pain-relieving) properties and is traditionally employed to treat various types of pain including peripheral neuropathy, menstrual discomfort, soft tissue injuries, and abdominal pain[4][7][8]. The main bioactive constituents are alkaloids such as tetrahydropalmatine (THP), protopine, berberine, corydaline, and others[7][8]. These compounds are believed to act on multiple biological targets involved in pain modulation and inflammation. Some studies suggest additional effects such as antiarrhythmic activity (heart rhythm regulation), anti-inflammatory action, sedative/hypnotic effects for relaxation or sleep support[4][7]. In traditional use it is also said to "move Qi" and stimulate blood flow. Mechanistically: - Alkaloids like THP may modulate dopamine receptors in the central nervous system. - Berberine can affect cytochrome P450 enzymes impacting drug metabolism. - Other alkaloids may interact with targets such as prostaglandin-endoperoxide synthase 1/2 (PTGS1/PTGS2), potassium voltage-gated channel subfamily H member 2 (KCNH2), sodium voltage-gated channel alpha subunit 5 (SCN5A), retinoid X receptor alpha (RXRA), calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2), nuclear receptor coactivator 2 (NCOA2) and estrogen receptor alpha (ESR1)[7]. Despite its long history of use and promising preclinical data for pain relief and other indications like arrhythmia or gastric ulcers[4][7], robust clinical evidence remains limited. Safety concerns exist regarding potential liver toxicity from certain alkaloids such as THP; caution is advised especially in vulnerable populations[4].

Other names
Corydalidis RhizomaCorydalis yanhusuo rhizomeYan Hu SuoXuanhuCorydalis ambigua tuberCorydalis ambigua rootCorydalidis Tuber
02

Targets

KCNH2 (Voltage-gated potassium channel subfamily H member 2)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)DRD2 (Dopamine D2 Receptor)SCN5A (Sodium channel protein type 5 subunit alpha)

Beyond the preview

Go deeper on corydalis rhizoma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on corydalis rhizoma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call